Talquetamab vs Real-World Physician's Choice in Patients With Relapsed/Refractory Multiple Myeloma and Prior B-Cell Maturation Antigen Therapy: Analyses of MonumenTAL-1 vs LocoMMotion/MoMMent

被引：0

作者：

Mateos Manteca, Maria-Victoria ^{[1
]}

Jakubowiak, Andrzej ^{[2
]}

Einsele, Hermann ^{[3
]}

Schinke, Carolina ^{[4
]}

Besemer, Britta ^{[5
]}

Anguille, Sebastien ^{[6
]}

Manier, Salomon ^{[7
]}

Rasche, Leo ^{[8
]}

Goldschmidt, Hartmut ^{[9
]}

van de Donk, Niels ^{[10
,11
]}

Perrot, Aurore ^{[12
]}

Teipel, Raphael ^{[13
]}

Karlin, Lionel ^{[14
]}

Scheid, Christof ^{[15
]}

San-Miguel, Jesus ^{[16
]}

Pawlyn, Charlotte ^{[17
,18
]}

Martinez-Lopez, Joaquin ^{[19
]}

Cavo, Michele ^{[20
]}

Diels, Joris ^{[21
]}

Renaud, Thomas ^{[22
]}

Orel, Oleksiy ^{[23
]}

Cabrieto, Jedelyn ^{[21
]}

Perualila, Nolen ^{[21
]}

Weisel, Katja ^{[24
]}

Moreau, Philippe ^{[25
]}

机构：

[1] Univ Hosp Salamanca, Inst Biomed Res Salamanca IBSAL, CIBERONC, Salamanca, Spain

[2] Univ Chicago, Chicago, IL USA

[3] Univ Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[4] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR USA

[5] Univ Tubingen, Tubingen, Germany

[6] Univ Antwerp, Antwerp Univ Hosp, Ctr Cell Therapy & Regenerat Med, Vaccine & Infect Dis Inst, Antwerp, Belgium

[7] Univ Lille, CHU Lille, Lille, France

[8] Univ Hosp Wurzburg, Wurzburg, Germany

[9] Univ Hosp Heidelberg, GMMG Study Grp, Dept Internal Med 5, Heidelberg, Germany

[10] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Hematol, Amsterdam, Netherlands

[11] Canc Ctr Amsterdam, Amsterdam, Netherlands

[12] Univ Toulouse, Serv Hematol, Toulouse, France

[13] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany

[14] Ctr Hosp Lyon Sud, Lyon, France

[15] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany

[16] Clin Univ Navarra, Navarra, Spain

[17] Inst Canc Res, London, England

[18] Royal Marsden NHS Fdn Trust, London, England

[19] Univ Complutense Madrid, CNIO Clin Res Unit H12O, CIBERONC, Dept Hematol,Hosp 12 Octubre, Madrid, Spain

[20] Univ Bologna, IRCCS Azienda Osped Univ Bologna, Ist Ematol Seragnoli, Bologna, Italy

[21] Janssen Pharmaceut NV, Beerse, Belgium

[22] Janssen Res & Dev, Raritan, NJ USA

[23] Janssen Cilag GmbH, Neuss, Germany

[24] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[25] Univ Hosp Hotel Dieu, Hematol Dept, Beirut, Lebanon

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-050

引用

页码：S69 / S70

页数：2

共 50 条

[21] Clinical updates of B-cell maturation antigen-targeted therapy in multiple myeloma (MM) and relapsed/refractory MM (Review)
Xing, Rui
Wang, Meidan
Wang, Liqun
Pan, Mingyue
Wang, Yixi
Zhou, Hongwei
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2025, 55 (02)
[22] Updated Results of Talquetamab, a GPRC5DxCD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma with Prior Exposure to T-Cell Redirecting Therapies: Results of the Phase 1/2 MonumenTAL-1 Study
Jakubowiak, Andrzej J.
Anguille, Sebastien
Karlin, Lionel
Chari, Ajai
Schinke, Carolina
Rasche, Leo
San-Miguel, Jesus
Campagna, Michela
Hilder, Brandi W.
Masterson, Tara J.
Qin, Xiang
Renaud, Thomas
Tolbert, Jaszianne
Vishwamitra, Deeksha
Skerget, Sheri
Moreau, Philippe
BLOOD, 2023, 142
[23] ADJUSTED COMPARISON OF TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN'S CHOICE (RWPC) OF THERAPY IN PATIENTS WITH TRIPLE-CLASS EXPOSED (TCE) RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Mateos, M., V
Chari, A.
Usmani, S. Z.
Goldschmidt, H.
Weisel, K.
Qi, K.
Londhe, A.
Nair, S.
Lin, X.
Pei, L.
Ammann, E.
Chastain, K.
Parekh, T.
Marshall, A.
Slavcev, M.
Moreau, P.
VALUE IN HEALTH, 2023, 26 (12) : S5 - S5
[24] COMPARATIVE EFFECTIVENESS OF TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN'S CHOICE OF THERAPY (RWPC) FOR PATIENTS WITH TRIPLE-CLASS EXPOSED (TCE) RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Krishnan, A.
Nooka, A.
Chari, A.
Garfall, A. L.
Martin, T.
Nair, S.
Lin, X.
Qi, K.
Londhe, A.
Pei, L.
Ammann, E.
Chastain, K.
Parekh, T.
Marshall, A.
Slavcev, M.
Usmani, S. Z.
VALUE IN HEALTH, 2023, 26 (12) : S37 - S37
[25] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed and refractory multiple myeloma: real-world experience
Hansen, Doris
Sidana, Surbhi
Peres, Lauren
Leitzinger, Christelle Colin
Shune, Leyla
Shrewsbury, Alexandria
Gonzalez, Rebecca
Sborov, Douglas
Wagner, Charlotte
Hashmi, Hamza
Kocoglu, Mehmet
Atrash, Shebli
Simmons, Gary
Kalariya, Nilesh
Ferreri, Christopher
Afrough, Aimaz
Kansagra, Ankit
Voorhees, Peter
Baz, Rachid
Khouri, Jack
Alsina, Melissa
McGuirk, Joseph
Locke, Frederick
Patel, Krina
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S2 - S3
[26] Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients
Scott Jew
Sean Bujarski
Bernard Regidor
Marsiye Emamy-Sadr
Regina Swift
Benjamin Eades
Susanna Kim
Shahrooz Eshaghian
James R. Berenson
Targeted Oncology, 2023, 18 : 735 - 747
[27] Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients
Jew, Scott
Bujarski, Sean
Regidor, Bernard
Emamy-Sadr, Marsiye
Swift, Regina
Eades, Benjamin
Kim, Susanna
Eshaghian, Shahrooz
Berenson, James R.
TARGETED ONCOLOGY, 2023, 18 (05) : 735 - 747
[28] Real-World Applicability of Commercial Chimeric Antigen Receptor T Cell Therapy Among Older Adults with Relapsed and/or Refractory Multiple Myeloma
Smith, Giri
Bal, Susan
Godby, Kelly N.
Ravi, Gayathri
Clark, Deanna
Ubersax, Clare
Cooley, Abigail
White, Priscila
Rangarajan, Sunil
Williams, Grant R.
Costa, Luciano J.
BLOOD, 2021, 138
[29] Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma
Beinfeld, Molly
Lee, Sei
McQueen, Brett
Fluetsch, Noemi
Pearson, Steven
Ollendorf, Daniel A.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 27 (09): : 1315 - 1320
[30] Expression of Myeloma Cell and Soluble B-Cell Maturation Antigen (BCMA) in Relapsed and Refractory Multiple Myeloma Patients Treated with GSK2857916 in BMA117159
Dettman, E. J.
Rigat, Fabio
Albert, Josh
Barnard, Ruth
Birchler, Mary
Deghenhardt, Yan
DeWall, Stephen
Gaye, Boyenoh
He, Zangdong
Liu, Veronica
Opalinska, Joanna
BLOOD, 2018, 132

← 1 2 3 4 5 →